Bioassays in Allergy: Technical Characteristics, Limitations, and Pathways to Clinical Implementation—An EAACI Position Paper

ABSTRACT Bioassays offer functional readouts of immune responses through specific biomarkers, providing mechanistic insight beyond conventional serology. By capturing cellular activation, tissue‐level changes, and molecular signaling, they hold promise for refining allergy diagnosis, risk stratification, and treatment monitoring, contributing to precision medicine. This review summarizes the current landscape of three allergy‐relevant bioassays: basophil activation test, histology, and molecular biology‐based assays. We discuss their underlying principles, clinical utilities as well as methodological and translational challenges and translational barriers. Attention is given to unmet needs such as assay standardization, reproducibility, and integration into clinical workflows. Finally, we outline future directions for research and clinical implementation, emphasizing the potential of bioassays to refine personalized management of allergic disorders. This position paper clearly distinguishes between descriptive summaries of the available evidence and the potential applicability recommendations of the EAACI Task Force, thereby enhancing clarity and interpretability for clinicians and researchers.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Allergy
Published
2026-09-30
DOI
https://doi.org/10.1002/clt2.70210
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Bioassays in Allergy: Technical Characteristics, Limitations, and Pathways to Clinical Implementation—An EAACI Position Paper

Edward F. Knol, Marina Pérez‐Gordo, C. Mayorga, Joana Vitte et al.
Clinical and Translational Allergy
Allergic Rhinitis and Sensitization
article

Bioassays in Allergy: Technical Characteristics, Limitations, and Pathways to Clinical Implementation—An EAACI Position Paper

Edward F. Knol, Marina Pérez‐Gordo, C. Mayorga, Joana Vitte, Araceli Díaz‐Perales, Bernadette Eberlein, Óscar Palomares, Rubén Fernández‐Santamaría, María Marta Escribese, Çağatay Karaaslan, Elena Izquierdo, Cristina Gómez‐Casado, Busra Kilic, Hj Hoffmann
article en

Abstract

ABSTRACT Bioassays offer functional readouts of immune responses through specific biomarkers, providing mechanistic insight beyond conventional serology. By capturing cellular activation, tissue‐level changes, and molecular signaling, they hold promise for refining allergy diagnosis, risk stratification, and treatment monitoring, contributing to precision medicine. This review summarizes the current landscape of three allergy‐relevant bioassays: basophil activation test, histology, and molecular biology‐based assays. We discuss their underlying principles, clinical utilities as well as methodological and translational challenges and translational barriers. Attention is given to unmet needs such as assay standardization, reproducibility, and integration into clinical workflows. Finally, we outline future directions for research and clinical implementation, emphasizing the potential of bioassays to refine personalized management of allergic disorders. This position paper clearly distinguishes between descriptive summaries of the available evidence and the potential applicability recommendations of the EAACI Task Force, thereby enhancing clarity and interpretability for clinicians and researchers.

Clinical and Translational AllergyVol. 16(10)
Universidad San Pablo CEU (ES), Universidad Complutense de Madrid (ES), Aarhus University (DK), University Medical Center Utrecht (NL), Centre Hospitalier Universitaire de Reims (FR), Hospital Regional Universitario de Málaga (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Centre for Plant Biotechnology and Genomics (ES), Technical University of Munich (DE), Universidad Autónoma de Madrid (ES), Hacettepe University (TR), Universidad Politécnica de Madrid (ES), Université de Reims Champagne-Ardenne (FR)
Openalex Percentile: Top 15%
Allergic Rhinitis and Sensitization
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.